An azole is a class of five-membered nitrogen heterocyclic ring compounds containing at least one other non-carbon atom of either nitrogen, sulfur, or oxygen. The parent compounds are aromatic and have two double bonds; there are successively reduced analogs (azolines and azolidines) with fewer. One, and only one, lone pair of electrons from each heteroatom in the ring is part of the aromatic bonding in an azole. Names of azoles maintain the prefix upon reduction (e.g., pyrazoline, pyrazolidine). The numbering of ring atoms in azoles starts with the heteroatom that is not part of a double bond, and then proceeds towards the other heteroatom.
- 1 nitrogen atom (but it only includes one nitrogen and no other heteroatom)
- 2 or more nitrogen atoms
- 1 nitrogen atom and 1 oxygen atom
- 1 nitrogen atom and 1 sulfur atom
Treatment for hyperthyrodism and or thyrotoxicosis
Alpha 1 adrenoreceptor blocker
Some people are allergic to azole(s).
Some of these drugs have adverse side effects.
Some azole drugs may disrupt estrogen production in pregnancy, affecting pregnancy outcome.
This article incorporates material from the Citizendium article "Azole", which is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License but not under the GFDL.
- Eicher, T.; Hauptmann, S. (June 2003). The Chemistry of Heterocycles: Structure, Reactions, Synthesis, and Applications (2nd ed.). John Wiley & Sons. ISBN 3527307206.
- Pinto A., Chan R.C. (April 2009). "Lack of Allergic Cross-Reactivity between Fluconazole and Voriconazole". American Society for Microbiology 53 (4): 1715–6. doi:10.1128/AAC.01500-08. PMC 2663085. PMID 19164151. Retrieved 2015-06-28.
- Stein GE, Christensen S, Mummaw N (June 1991). "Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis". DICP 25 (6): 582–5. PMID 1877264. Retrieved 2009-11-11.
- Kragie L, Turner SD, Patten CJ, Crespi CL, Stresser DM (August 2002). "Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay". Endocr. Res. 28 (3): 129–40. doi:10.1081/ERC-120015045. PMID 12489563.